S19-1011   Click here for help

GtoPdb Ligand ID: 14599

Synonyms: compound 17a [PMID: 36566714]
Compound class: Synthetic organic
Comment: S19-1011 is a selective aldo-keto reductase family 1 member C3 (AKR1C3) inhibitor [1]. AKR1C3 (a phase I biotransformation enzyme) is overexpressed in hormone related cancers and is responsible for resistance to key chemotherapeutics such as doxorubicin and gemcitabine. AKR1C3 inhibitors are proposed to restore sensitivity to these widely used anti-tumour drugs.

S19-1011 was used as the targeting ligand in the design of the small molecule-drug conjugate SM-27 [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 59.92
Molecular weight 322.36
XLogP 2.29
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=NOC(=C1COC2=C(C=CC=C2)C(=O)NC3=CC=CC=C3)C
Isomeric SMILES CC1=NOC(=C1COC2=C(C(=O)NC3=CC=CC=C3)C=CC=C2)C
InChI InChI=1S/C19H18N2O3/c1-13-17(14(2)24-21-13)12-23-18-11-7-6-10-16(18)19(22)20-15-8-4-3-5-9-15/h3-11H,12H2,1-2H3,(H,20,22)
InChI Key SZPZAEMMLAMRGF-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Liu Y, Chen Y, Jiang J, Chu X, Guo Q, Zhao L, Feng F, Liu W, Zhang X, He S et al.. (2023)
Development of highly potent and specific AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer.
Eur J Med Chem, 247: 115013. [PMID:36566714]
2. Wang X, Guo C, Liu Y, Han B, Zhang L, Liu Z, Chen Y, Sun H. (2026)
Design, Synthesis, and Biological Evaluation of a Cathepsin B-Activated Small Molecule-Drug Conjugate Targeting AKR1C3 to Enhance Chemotherapeutic Selectivity.
J Med Chem, [Epub ahead of print]. [PMID:42470376]